Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    11.00 (1.59%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Shares Cancellation & New Share Buy-Back Programme

14 Nov 2023 07:00

RNS Number : 3067T
B.P. Marsh & Partners PLC
14 November 2023
 

14 November 2023

 

B.P. Marsh & Partners Plc

B.P. Marsh & Partners Plc ("B.P. Marsh" or the "Company")

 

Cancellation of Shares and New Share Buy-Back Programme

 

Cancellation of Shares

 

B.P. Marsh today announces that on 9 November 2023 it cancelled 178,000 ordinary shares of 10p each ("Ordinary Shares"). These shares were previously held in treasury, taking the total number of shares held by the Company in Treasury to 60,097 shares.

 

As a result of the cancellation, the total number of Ordinary Shares in issue is 37,288,000 and the total number of Voting Rights in B.P. Marsh is 37,227,903. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

New Share Buy-Back Programme

 

B.P. Marsh today announces that it will undertake a share buy-back programme of a maximum aggregate consideration of £500,000, and subject to the Ordinary Shares being available to purchase at a price representing a discount of at least 20% to the most recently announced NAV per share of 567.3p (the "Share Buyback Programme").

 

The Company is of the view that the previous Buyback programme that it operated between 16 January 2023 and 29 September 2023 was a successful and value accretive initiative, and one which it would like to continue for the remainder of the year.

 

The Company has appointed its corporate broker, Panmure Gordon (UK) Limited ("Panmure Gordon") to manage the Share Buyback Programme to repurchase Ordinary Shares on its behalf from today's date until 21 December 2023.

 

The Company has entered into an irrevocable commitment with Panmure Gordon to continue the Share Buyback Programme through a non-discretionary programme, repurchasing the Company's Ordinary Shares on its behalf, and within certain defined parameters. Panmure Gordon will make trading decisions in relation to the buyback of Ordinary Shares independently of the Company within the programme terms.

 

Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price, trading volume and other terms. The maximum price paid per Ordinary Share will be no more than the higher of the price of the last independent trade and the highest current independent purchase bid for Ordinary Shares on the trading venue where the purchase is carried out. Under the Share Buyback Programme, the repurchased shares will be held in treasury at the Company's discretion for later reissue or cancellation. Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

 

The Share Buyback Programme will operate in accordance with the Company's general authority to purchase a maximum of 3,746,600 Ordinary Shares (the "Authority"), granted by its shareholders at the Annual General Meeting of the Company held on 26 July 2023 (since when the Company has repurchased 80.199 Ordinary Shares pursuant to the Authority). The purpose of the Share Buyback Programme is to reduce the Company's share capital. The Share Buyback Programme will be conducted within the parameters of the Market Abuse Regulation 596/2014/EU and the delegated regulations made pursuant to it. The Company confirms that it currently has no unpublished price sensitive information.

 

The Company will make further regulatory announcements in respect of repurchases of Ordinary Shares as required by UK MAR and the AIM Rules.

 

This announcement contains information which, prior to its disclosure, was inside information.

 

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

 

 

 

 

Nominated Adviser & Broker

Panmure Gordon

 

Atholl Tweedie / Amrit Mahbubani / Stephen Jones / Ailsa MacMaster

+44 (0)20 7886 2500

 

 

 

 

Financial PR & Investor Relations

 

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson / Katie Hopkins

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fourteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBJBTTMTTBTBJ
Date   Source Headline
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:01 amRNSFinal Results for the Year to 31 January 2026
27th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSNotice of Results and Investor Presentation
24th Apr 20265:50 pmRNSTransaction in Own Shares
20th Apr 20265:25 pmRNSSIP Awards, PDMR Dealings, Treasury Shares, TVR
16th Apr 20267:00 amRNSDeferred Consideration Receipt & Special Dividend
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSFollow-on equity purchase in Pantheon
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20263:52 pmRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSNew Share Buyback Programme
18th Mar 20267:00 amRNSNew Investment: Nine Edge Wealth Limited
18th Mar 20267:00 amRNSNew Investment: Ventura Risk Partners Holdings
17th Mar 20264:48 pmRNSSale of Interest in Amiga to Sodalis
11th Mar 20267:00 amRNSUpdate on Sodalis Capital Limited
24th Feb 20267:00 amRNSTrading Update
6th Feb 20267:00 amRNSPurchase of Own Shares and Total Voting Rights
5th Feb 202611:44 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSInterim Dividend Declaration
18th Dec 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
15th Dec 20257:00 amRNSSpecial Dividend Declaration
11th Dec 20257:00 amRNSAppointment of Nominated Adviser and Joint Brokers
2nd Dec 20257:00 amRNSChange in Executive Directorship Roles
27th Nov 20256:17 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSNew Investment: Sodalis Capital Limited
25th Nov 20254:55 pmRNSTransaction in Own Shares
24th Nov 20255:05 pmRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:57 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 202512:38 pmRNS-RB.P. Marsh to present at MelloLondon
11th Nov 20255:08 pmRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:01 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSSale of Stewart Specialty Risk Underwriting
27th Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSHalf-year Results
7th Oct 202511:15 amRNSNotice of HY Results and Investor Presentation
30th Sep 20253:52 pmRNSNew Investment: Oneglobal Broking Holdings Limited
23rd Sep 20257:00 amRNSTrading Update
22nd Sep 20253:23 pmRNSNew Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.